搜尋結果
藥明巨諾與2seventy bio宣佈達成戰略合作,加速T細胞免疫治療的研發
PR Newswire Asia· 2 年前雙方的首要合作是在中國加速開發用於治療實體腫瘤的2seventy的MAGE-A4項目 中國上海和美國馬薩諸塞州 ...
Peloton Releases Second Annual Environmental, Social, and Governance (ESG) Report
ACCESSWIRE· 2 年前Peloton Interactive Inc. (NASDAQ:PTON) announced the publication of its second annual ESG report outlining recent progress made in its fiscal ...